1[1]Huang JQ,Sridhar s,Hunt RH.Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease:a meta-analysis.Lancet 2002;359:14-22.
2[2]Chan FKL,To KF,Wu JCY,et al.Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs:a randomized trial.Lancet 2002;359:9-13.
3[3]Hawkey CJ,Tulassay Z,szczepanski L,et al.Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs:HELP NSAIDs study.Lancet 1998;352:1016-1021.
4[4]Chan FKL,Chung SCS,Suen BY,et al.Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.N Engl J Med 2001 ;344:967-973.
5[5]Kelly JP,Kaufman DW,Jurgelon JM,et al.Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product.Lancet 1996;348:1413-1416.
6[6]Well J,Colin-Jones D,Langman M,et al.Prophylactic aspirin and risk of pOeptic ulcer bleeding.BMJ 1995;310:827-830.
7[7]Lai KC,Lam SK,Chu KM,et al.Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.N Engl J Med 2002;346:2033-2038.
8[8]Chan FKL,Sung JJY,Suen R,et al.Does eradication of Helicobacterpylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study.Aliment Pharmacol Ther 1998;12:1201-1205.
9[9]Bianchi Porro G,Parente F,Imbesi V,et al Role of Helicobacter pylori in ulcer healing and recurrences of gastric and duodenal ulcers in long term NSAID users:response to omeprazole dual therapy.Gut 1996;39:22-26.
10[10]Malfertheiner P,Megraud F,O'morain C,et al.Current concepts in the management of Helicobacter pylori infection-The Maastricht 2-2000 Consensus Report.Aliment Pharmacol Ther 2002;16:167-180.
二级参考文献2
1Malfertheiner P, Megraud F, O′Morain C, et al. European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection: the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther,2002 ,16:167-180.
5Peterson WL, Fendrick AM, Cave DR, et al. Helicobacter pylori related disease: guidelines for testing and treatment [ J ]. Arch Intern Med,2000,160:1285 - 1291.
6Malfertheiner P, Peitz U, Treiber G. What constitutes failure for Helicobacter pylori eradication therapy? [ J ]. Can J Gastroenterol,2003,17 ( Suppl B ) :53 - 57.
7Malfertheiner P, Megraud F, O' Morain C, et al. Current concepts in the management of Helicobacter pylon infection : the Maastricht Ⅲ Consensus Report [ J ]. Gut,2007,56 (6) :772 - 781.
8Kim NY,Kim JM,Kim CH,et al. Institutional difference of antibiotic resistance of Helicobacter pylori swains in Korea[ J]. J Clin Gastroenterol,2006 ,40 :683 - 687.
10Antithrombotic Trialists' Collaboration.Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high risk patients[J].BMJ, 2002,524: 71-86.
